PubMed Health⌕ Search

Biomedical subjects

Chi P Dola

Publications and source records attributed to Chi P Dola.

2 recordsLinked to original sources
PubMed2003

Placenta previa: does its type affect pregnancy outcome?

Our objective was to compare pregnancy outcomes associated with different types of placenta previa. This is a retrospective analysis of pregnancies complicated by placenta previa, from January 1990 to December 1997. Descriptive statistics and comparison analyses were performed. One hundred seventy-five singleton pregnancies beyond 24 weeks that were complicated by complete, partial, or marginal previa were included. Differences in pregnancy outcomes between complete, partial, and marginal previas were: onset of bleeding (29.9 +/- 4.5 versus 32.5 +/- 6.9 versus 32.7 +/- 5.0 weeks, respectively, p < 0.05), antepartum hospitalization (60.7% versus 38.1% versus 35.1%, respectively, p < 0.05), gestation at delivery (34.7 +/- 3.1 versus 37.4 +/- 2.6 versus 36.1 +/- 3.0 weeks, respectively, p < 0.05), birth weight (2498.3 +/- 746.8 versus 2978.8 +/- 568.3 versus 2813.4 +/- 728.4 g, respectively, p < 0.05), and hysterectomy at time of cesarean delivery (20.5% versus 0% versus 8.1%, respectively, p < 0.05). For all outcome parameters, the partial and marginal previa groups did not differ. Women with complete placenta previa, as diagnosed with modern ultrasound techniques, had poorer pregnancy outcome. They were more likely to deliver prematurely and were more likely to require a hysterectomy at the time of cesarean delivery.

Adult↗
PubMed2003

Preeclampsia and eclampsia revisited.

Hypertensive disorders during pregnancy, which account for approximately 15% of pregnancy-related deaths, represent the second-leading cause of morbidity and mortality in the United States. New classifications recommended by the National Institutes of Health's Working Group on High Blood Pressure in Pregnancy have decreased the confusion often associated with these disorders. The cause of preeclampsia-eclampsia still remains elusive, but continued research has provided hope with regard to screening, improved diagnosis, and management. Risk factors that have recently gained attention include inherited thrombophilias, inherited metabolic disorders, and lipid disorders. Treatment and management of the hypertensive disorders of pregnancy have not changed substantially in the past 50 years. Prevention of preeclampsia-eclampsia has been unsuccessful, and recurrence risks remain high. Careful diagnosis, classification, and further investigation of the causes of hypertensive disorders in pregnancy are needed to achieve optimal management of affected women and their fetuses.

Eclampsia↗